Indoor rock climbing (bouldering) as a new treatment for depressio
- Conditions
- DepressionMental and Behavioural Disorders
- Registration Number
- ISRCTN17623318
- Lead Sponsor
- Psychiatric University Hospital Erlangen (Germany)
- Brief Summary
2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26302900 results 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31872117/ (added 18/08/2023) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29862344/ (added 18/08/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
1. Diagnosis of depression by a psychiatrist or less than 13 points on the WHO depression scale,
2. Informed consent
3. Having free time on Thursday mornings during the intervention period
4. BMI between 18.5 and 35
1. Undergoing in-patient treatment during either the intervention or the waiting periods
2. Acute suicidality or psychosis
3. Medical contraindication against sport, determined by a GP or psychiatrist
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The BDI-II is used to measure the intensity of depression. Measured at baseline (t0), after 8 weeks (t1), 16 weeks (t2), and 24 weeks (t3).
- Secondary Outcome Measures
Name Time Method 1. SCL-90-R (global intensity of psychological symptoms and distress)<br>2. FERUS (individuals' health-related resources and manageability)<br>3. d2-R (attention and concentration performance)<br>Measured at baseline (t0), after 8 weeks (t1), 16 weeks (t2), and 24 weeks (t3).